Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Researchers identify key protein in immune response to malaria and TB

An international team of researchers has identified a key protein involved in the immune system's response to malaria, tuberculosis (TB) and a number of other infectious diseases. The insights suggest possible new therapies to tackle these major global diseases.

28 Mar 2007

FDA needs authority to approve generic biologics

AARP called on Congress today to give the Food and Drug Administration (FDA) the authority to approve safe, cost-effective generic versions of often expensive biologic drug therapies.

8 Mar 2007

New Crohn's disease treatment Humira promises to reduce symptoms

The Food and Drug Administration (FDA) in the United States has given it's approval for the use of the drug Humira (adalimumab) to treat adults suffering from Crohn's disease.

28 Feb 2007

Relationship between appearance and psychological distress in rheumatic diseases

Patients with rheumatic disease can experience physical deformities, especially of the hands and feet in the case of rheumatoid arthritis (RA), or skin rashes and lesions and hand deformity in the case of systemic lupus erthyematosus.

28 Feb 2007

FDA approves Humira (adalimumab) for Crohn's disease

The U.S. Food and Drug Administration (FDA) today approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn's disease, a chronic inflammatory disease of the intestines, which affects an estimated one million Americans.

27 Feb 2007

Influence of inflammatory polyarthritis on cancer incidence and survival

Patients with rheumatoid arthritis (RA), a chronic inflammatory autoimmune disease, have a high risk of death from disease - at least double the risk of the general population, studies overwhelmingly show. Evidence has been less clear on whether RA patients are exceptionally vulnerable to dying from cancer.

27 Feb 2007

More evidence that inflammation can fuel cancer

As evidence mounts that the body's normally protective inflammation response can drive some precancerous tissues to become fully malignant, UCSF scientists report discovering an apparent trigger to this potentially deadly process.

19 Feb 2007

Insulin-like growth factor receptor implicated in development of Graves' disease

Investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) have found evidence that continues to implicate insulin-like growth factor receptor (IGF-1R) in the development of Graves' disease.

18 Feb 2007

Thailand holds drug giants over a barrel

The government of Thailand, has already upset some of the big drug companies by overriding patent licenses for generic versions of heart and HIV/AIDS pills, and is now planning to go one step further unless drug giants cut their prices.

13 Feb 2007

4SC granted U.S. patent for drug to treat rheumatoid arthritis

Martinsried-based drug discovery and development company 4SC AG announced today that the US Patent and Trademark Office (ASPTO) has granted the patent with the US patent number 7,176,241 for its drug candidate SC12267.

6 Feb 2007

New method of predicting rheumatoid arthritis offers early help to sufferers

Dutch researchers believe they may have come up with a new way of predicting whether patients with arthritic symptoms will progress to the autoimmune form of the disease, rheumatoid arthritis.

31 Jan 2007

A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis

Marked by chronic inflammation of the joints and tissue, rheumatoid arthritis (RA) is a painful and potentially disabling autoimmune disease.

30 Jan 2007

Possible reason for severe side-effects of Northwick Park clinical trial

A possible reason why the Northwick Park clinical trial of the drug TGN1412 caused multiple organ failure in human volunteers is revealed in research presented at a conference near Paris.

25 Jan 2007

Successor to Vioxx fails to quell concerns

When drug company Merck revealed the the results of a study this week over it's successor to Vioxx, the new arthritis drug Arcoxia, it did little to quell concerns about both the use and the safety of the new drug.

15 Nov 2006

Arthritis drugs not as risky as first thought

Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.

8 Nov 2006

Acupuncture and Turmeric could be viable treatment options for arthritis sufferers

People who suffer from osteoarthritis (OA) as a rule find it has to varying degrees an impact on their mobility and quality of life.

31 Oct 2006

Turmeric for prevention of rheumatoid arthritis and osteoporosis

An ancient spice, long used in traditional Asian medicine, may hold promise for the prevention of both rheumatoid arthritis and osteoporosis, according to a recently completed study at The University of Arizona College of Medicine.

30 Oct 2006

Researchers create roadmap to integrin activation

Calling it an important technical advance in the study of the complex receptors and pathways of the body's cellular system, researchers at the University of California, San Diego (UCSD) School of Medicine have reconstructed the signaling pathways that impact activation of a receptor that is critical to the control of bleeding and to the thrombosis that occurs in heart attacks and strokes.

18 Sep 2006

Are we getting enough vitamin D?

Scientists from the University of Ulster are to explore if we are getting enough vitamin D - vital for the formation of healthy bones and which may also help prevent diseases such as diabetes, cancers, rheumatoid arthritis and multiple sclerosis.

13 Sep 2006

Drug infliximab may help ease ulcerative colitis

In good news for patients with stubborn cases of ulcerative colitis, a serious intestinal disorder, a new research review suggests that the drug infliximab can be a useful alternative if other treatments don't work.

12 Sep 2006